CN113925946A - 一种疏肝解郁中药及其制备方法 - Google Patents
一种疏肝解郁中药及其制备方法 Download PDFInfo
- Publication number
- CN113925946A CN113925946A CN202111414634.8A CN202111414634A CN113925946A CN 113925946 A CN113925946 A CN 113925946A CN 202111414634 A CN202111414634 A CN 202111414634A CN 113925946 A CN113925946 A CN 113925946A
- Authority
- CN
- China
- Prior art keywords
- parts
- portions
- traditional chinese
- chinese medicine
- liver
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 47
- 210000004185 liver Anatomy 0.000 title claims abstract description 41
- 238000002360 preparation method Methods 0.000 title abstract description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 31
- 241000237502 Ostreidae Species 0.000 claims abstract description 26
- 235000020636 oyster Nutrition 0.000 claims abstract description 26
- 241000202726 Bupleurum Species 0.000 claims abstract description 25
- 240000007126 Citrus medica var. sarcodactylis Species 0.000 claims abstract description 23
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims abstract description 23
- 239000000341 volatile oil Substances 0.000 claims abstract description 22
- 239000002994 raw material Substances 0.000 claims abstract description 20
- 244000150195 Cyperus longus Species 0.000 claims abstract description 14
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims abstract description 9
- 238000002156 mixing Methods 0.000 claims abstract description 9
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 8
- 238000000034 method Methods 0.000 claims abstract description 7
- 210000000988 bone and bone Anatomy 0.000 claims abstract description 6
- 244000163122 Curcuma domestica Species 0.000 claims abstract description 5
- 235000003392 Curcuma domestica Nutrition 0.000 claims abstract description 5
- 235000003373 curcuma longa Nutrition 0.000 claims abstract description 5
- 235000013976 turmeric Nutrition 0.000 claims abstract description 5
- 229940013618 stevioside Drugs 0.000 claims description 19
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 19
- 235000019202 steviosides Nutrition 0.000 claims description 19
- 244000164480 Curcuma aromatica Species 0.000 claims description 15
- 235000003398 Curcuma aromatica Nutrition 0.000 claims description 15
- 244000236658 Paeonia lactiflora Species 0.000 claims description 13
- 235000008598 Paeonia lactiflora Nutrition 0.000 claims description 13
- 244000241838 Lycium barbarum Species 0.000 claims description 9
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 9
- 235000015468 Lycium chinense Nutrition 0.000 claims description 9
- 235000013399 edible fruits Nutrition 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 9
- 241000212941 Glehnia Species 0.000 claims description 7
- 235000017784 Mespilus germanica Nutrition 0.000 claims description 7
- 244000182216 Mimusops elengi Species 0.000 claims description 7
- 235000000560 Mimusops elengi Nutrition 0.000 claims description 7
- 235000006484 Paeonia officinalis Nutrition 0.000 claims description 7
- 241001106477 Paeoniaceae Species 0.000 claims description 7
- 235000007837 Vangueria infausta Nutrition 0.000 claims description 7
- 239000000284 extract Substances 0.000 claims description 7
- 210000000582 semen Anatomy 0.000 claims description 7
- 229920001353 Dextrin Polymers 0.000 claims description 6
- 239000004375 Dextrin Substances 0.000 claims description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 6
- 235000019425 dextrin Nutrition 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 239000012530 fluid Substances 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 238000001694 spray drying Methods 0.000 claims description 6
- 238000005406 washing Methods 0.000 claims description 6
- 238000005303 weighing Methods 0.000 claims description 6
- 244000183685 Citrus aurantium Species 0.000 claims description 5
- 235000007716 Citrus aurantium Nutrition 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 4
- 229920000858 Cyclodextrin Polymers 0.000 claims description 3
- 239000001116 FEMA 4028 Substances 0.000 claims description 3
- 235000011175 beta-cyclodextrine Nutrition 0.000 claims description 3
- 229960004853 betadex Drugs 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 239000003208 petroleum Substances 0.000 claims description 3
- 238000005086 pumping Methods 0.000 claims description 3
- 239000008213 purified water Substances 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 3
- 238000002791 soaking Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 208000002193 Pain Diseases 0.000 abstract description 10
- 230000000694 effects Effects 0.000 abstract description 10
- 230000036407 pain Effects 0.000 abstract description 10
- 230000000144 pharmacologic effect Effects 0.000 abstract description 7
- 238000001556 precipitation Methods 0.000 abstract description 6
- 230000001105 regulatory effect Effects 0.000 abstract description 6
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 abstract description 5
- 206010022998 Irritability Diseases 0.000 abstract description 5
- 206010036618 Premenstrual syndrome Diseases 0.000 abstract description 5
- 229940079593 drug Drugs 0.000 abstract description 5
- 206010008479 Chest Pain Diseases 0.000 abstract description 4
- 206010013954 Dysphoria Diseases 0.000 abstract description 4
- 206010019233 Headaches Diseases 0.000 abstract description 4
- 210000000481 breast Anatomy 0.000 abstract description 4
- 208000002173 dizziness Diseases 0.000 abstract description 4
- 231100000869 headache Toxicity 0.000 abstract description 4
- 239000000126 substance Substances 0.000 abstract description 4
- 206010000060 Abdominal distension Diseases 0.000 abstract description 3
- 244000272264 Saussurea lappa Species 0.000 abstract description 3
- 235000006784 Saussurea lappa Nutrition 0.000 abstract description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 abstract description 3
- QTCANKDTWWSCMR-UHFFFAOYSA-N costic aldehyde Natural products C1CCC(=C)C2CC(C(=C)C=O)CCC21C QTCANKDTWWSCMR-UHFFFAOYSA-N 0.000 abstract description 3
- 239000012535 impurity Substances 0.000 abstract description 3
- 239000004615 ingredient Substances 0.000 abstract description 3
- 206010022437 insomnia Diseases 0.000 abstract description 3
- ISTFUJWTQAMRGA-UHFFFAOYSA-N iso-beta-costal Natural products C1C(C(=C)C=O)CCC2(C)CCCC(C)=C21 ISTFUJWTQAMRGA-UHFFFAOYSA-N 0.000 abstract description 3
- 230000001376 precipitating effect Effects 0.000 abstract description 3
- 229940126532 prescription medicine Drugs 0.000 abstract description 3
- 210000002784 stomach Anatomy 0.000 abstract description 3
- 235000018109 Cyperus longus Nutrition 0.000 abstract 1
- 244000075634 Cyperus rotundus Species 0.000 abstract 1
- 244000116484 Inula helenium Species 0.000 abstract 1
- 235000002598 Inula helenium Nutrition 0.000 abstract 1
- 235000005010 Scirpus paludosus Nutrition 0.000 abstract 1
- 238000011160 research Methods 0.000 description 6
- 206010010904 Convulsion Diseases 0.000 description 3
- 230000002633 protecting effect Effects 0.000 description 3
- 230000002936 tranquilizing effect Effects 0.000 description 3
- ULDHMXUKGWMISQ-VIFPVBQESA-N (+)-carvone Chemical compound CC(=C)[C@H]1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-VIFPVBQESA-N 0.000 description 2
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 2
- ZIXLDMFVRPABBX-UHFFFAOYSA-N 2-methylcyclopentan-1-one Chemical compound CC1CCCC1=O ZIXLDMFVRPABBX-UHFFFAOYSA-N 0.000 description 2
- BGEBZHIAGXMEMV-UHFFFAOYSA-N 5-methoxypsoralen Chemical compound O1C(=O)C=CC2=C1C=C1OC=CC1=C2OC BGEBZHIAGXMEMV-UHFFFAOYSA-N 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- KYWSCMDFVARMPN-LCSVLAELSA-N Saikosaponin D Chemical compound O([C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@]([C@H]3[C@]([C@@H]4[C@@]([C@@]5(C[C@@H](O)[C@]67CO[C@]5([C@@H]6CC(C)(C)CC7)C=C4)C)(C)CC3)(C)CC2)(C)CO)O[C@@H]([C@@H]1O)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O KYWSCMDFVARMPN-LCSVLAELSA-N 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 2
- UAHWPYUMFXYFJY-UHFFFAOYSA-N beta-myrcene Chemical compound CC(C)=CCCC(=C)C=C UAHWPYUMFXYFJY-UHFFFAOYSA-N 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 2
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 2
- 229940025878 hesperidin Drugs 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 229930192014 saikosaponin Natural products 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 235000017709 saponins Nutrition 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- QGJZLNKBHJESQX-UHFFFAOYSA-N 3-Epi-Betulin-Saeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(=C)C)C5C4CCC3C21C QGJZLNKBHJESQX-UHFFFAOYSA-N 0.000 description 1
- CLOUCVRNYSHRCF-UHFFFAOYSA-N 3beta-Hydroxy-20(29)-Lupen-3,27-oic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C(O)=O)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C CLOUCVRNYSHRCF-UHFFFAOYSA-N 0.000 description 1
- SMRPGWBDLOQHOS-UHFFFAOYSA-N 5-[4,5-dihydroxy-6-(hydroxymethyl)-3-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxy-3,4-dihydroxy-6-[[9-hydroxy-4-(hydroxymethyl)-4,6a,6b,8a,11,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1H-picen-3-yl]oxy]oxane-2-carboxylic acid Chemical compound OC1C(O)C(O)C(C)OC1OC1C(OC2C(OC(C(O)C2O)C(O)=O)OC2C(C3C(C4C(C5(CCC6(C)C(O)CC(C)(C)CC6C5=CC4=O)C)(C)CC3)(C)CC2)(C)CO)OC(CO)C(O)C1O SMRPGWBDLOQHOS-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 1
- QQUHMASGPODSIW-UHFFFAOYSA-N Albiflorin Natural products C=1C=CC=CC=1C(=O)OCC12C(=O)OC3(C)CC(O)C1CC32OC1OC(CO)C(O)C(O)C1O QQUHMASGPODSIW-UHFFFAOYSA-N 0.000 description 1
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- DBMJZOMNXBSRED-UHFFFAOYSA-N Bergamottin Natural products O1C(=O)C=CC2=C1C=C1OC=CC1=C2OCC=C(C)CCC=C(C)C DBMJZOMNXBSRED-UHFFFAOYSA-N 0.000 description 1
- DIZWSDNSTNAYHK-XGWVBXMLSA-N Betulinic acid Natural products CC(=C)[C@@H]1C[C@H]([C@H]2CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(=O)O DIZWSDNSTNAYHK-XGWVBXMLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010015137 Eructation Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- JYDNKGUBLIKNAM-UHFFFAOYSA-N Oxyallobutulin Natural products C1CC(=O)C(C)(C)C2CCC3(C)C4(C)CCC5(CO)CCC(C(=C)C)C5C4CCC3C21C JYDNKGUBLIKNAM-UHFFFAOYSA-N 0.000 description 1
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 1
- CWRVKFFCRWGWCS-UHFFFAOYSA-N Pentrazole Chemical compound C1CCCCC2=NN=NN21 CWRVKFFCRWGWCS-UHFFFAOYSA-N 0.000 description 1
- 241000183024 Populus tremula Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- QQUHMASGPODSIW-ICECTASOSA-N albiflorin Chemical compound O([C@@]12C[C@H]3[C@H](O)C[C@@]1(OC(=O)[C@]32COC(=O)C=1C=CC=CC=1)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O QQUHMASGPODSIW-ICECTASOSA-N 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- VYBREYKSZAROCT-UHFFFAOYSA-N alpha-myrcene Natural products CC(=C)CCCC(=C)C=C VYBREYKSZAROCT-UHFFFAOYSA-N 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 208000027687 belching Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229960002045 bergapten Drugs 0.000 description 1
- KGZDKFWCIPZMRK-UHFFFAOYSA-N bergapten Natural products COC1C2=C(Cc3ccoc13)C=CC(=O)O2 KGZDKFWCIPZMRK-UHFFFAOYSA-N 0.000 description 1
- FVWJYYTZTCVBKE-ROUWMTJPSA-N betulin Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(CO)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C FVWJYYTZTCVBKE-ROUWMTJPSA-N 0.000 description 1
- MVIRREHRVZLANQ-UHFFFAOYSA-N betulin Natural products CC(=O)OC1CCC2(C)C(CCC3(C)C2CC=C4C5C(CCC5(CO)CCC34C)C(=C)C)C1(C)C MVIRREHRVZLANQ-UHFFFAOYSA-N 0.000 description 1
- QGJZLNKBHJESQX-FZFNOLFKSA-N betulinic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C QGJZLNKBHJESQX-FZFNOLFKSA-N 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Natural products CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- PZXJOHSZQAEJFE-UHFFFAOYSA-N dihydrobetulinic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(C)C)C5C4CCC3C21C PZXJOHSZQAEJFE-UHFFFAOYSA-N 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- -1 flavonoid compounds Chemical class 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 229930003658 monoterpene Natural products 0.000 description 1
- 150000002773 monoterpene derivatives Chemical class 0.000 description 1
- 235000002577 monoterpenes Nutrition 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- MQYXUWHLBZFQQO-UHFFFAOYSA-N nepehinol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C MQYXUWHLBZFQQO-UHFFFAOYSA-N 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 239000009835 oxypaeoniflora Substances 0.000 description 1
- FCHVXNVDFYXLIL-QYDSDWLYSA-N oxypaeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@@]1(C[C@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=C(O)C=C1 FCHVXNVDFYXLIL-QYDSDWLYSA-N 0.000 description 1
- RLXWQODPAWIVOI-UHFFFAOYSA-N oxypaeoniflorin Natural products OCC1OC(OC23CC4C5(O)CC2OC(O5)C34COC(=O)c6ccc(O)cc6)C(O)C(O)C1O RLXWQODPAWIVOI-UHFFFAOYSA-N 0.000 description 1
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- PPRSVUXPYPBULA-UHFFFAOYSA-N saponin A Natural products CC1(C)CCC2(CCC3(C)C(=CCC4C5(C)CCC(OC6OC(CO)C(O)C(O)C6=O)C(C)(C)C5CCC34C)C2C1)C(=O)O PPRSVUXPYPBULA-UHFFFAOYSA-N 0.000 description 1
- 229930182947 sarcodictyin Natural products 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/285—Aucklandia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
- A61K36/8905—Cyperus (flatsedge)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Marine Sciences & Fisheries (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种中药配方及工艺,具体是一种疏肝解郁中药及其制备方法,该中药包括以下原料:柴胡、白芍、北沙参、香附、郁金、枸杞子、酸枣仁、龙骨、牡蛎、枳壳、佛手、木香、甜菊素。该中药具有疏肝解郁,理气和中的功能。拟治妇科经前期综合征,适用于肝郁气滞所致的经前乳房胀痛,胸闷肋涨,头晕头痛,烦躁易怒,失眠多梦等;通过对处方药物化学成分理化性质及药理作用的检索,结合本品的临床功效,确定柴胡、香附、郁金、木香四味先提取挥发油,并将挥发油用β‑CD包合。药渣再与白芍等六味合并水煎提取,水煎液浓缩后用乙醇沉淀除杂。龙骨、牡蛎为了避免和群药共煎醇沉时有效成分损失,因此将二味单独煎煮浓缩后加入上述醇沉后的浓缩液中。
Description
技术领域
本发明涉及一种中药配方及工艺,具体是一种疏肝解郁中药及其制备方法。
背景技术
疏肝亦称“疏肝”,或“疏肝解郁”。属于和法之一。肝主疏泄,性喜条达而恶抑郁;脾主运化,为气血生化之源;肝脾生理上相互协调、相互为用,肝气郁结易招木旺乘土。
随着社会的发展,工作以及生活节奏的加快,越来越多的人因情志抑郁不畅,或精神刺激,致使肝失疏泄,肝气郁结。常表现为两胁胀痛或窜痛,胸闷不舒,情绪急躁易怒,或嗳气吞酸,恶心呕吐,腹痛腹泻,妇女月经不调或经行腹痛等症。
发明内容
本发明的目的在于提供一种疏肝解郁中药及其制备方法,以解决上述背景技术中提出的问题。
为实现上述目的,本发明提供如下技术方案:
一种疏肝解郁中药,包括以下重量份的原料:柴胡210-230份;白芍420-455份;北沙参420-455份;香附314-345份;郁金312-344份;枸杞子420-455份;酸枣仁422-460份;龙骨422-460份;牡蛎422-460份;枳壳321-350份;佛手151-175份;木香150-173份;甜菊素13-21份。
作为本发明进一步的方案:疏肝解郁中药包括以下重量份的原料:柴胡214-227份;白芍426-449份;北沙参426-449份;香附320-342份;郁金318-341份;枸杞子426-449份;酸枣仁430-455份;龙骨430-455份;牡蛎430-455份;枳壳326-344份;佛手154-171份;木香153-170份;甜菊素14-20份。
作为本发明再进一步的方案:疏肝解郁中药包括以下重量份的原料:柴胡218-225份;白芍432-445份;北沙参432-445份;香附325-339份;郁金324-338份;枸杞子432-445份;酸枣仁435-450份;龙骨435-450份;牡蛎435-450份;枳壳330-342份;佛手160-168份;木香159-167份;甜菊素15-19份。
作为本发明再进一步的方案:疏肝解郁中药包括以下重量份的原料:柴胡220-224份;白芍435-443份;北沙参435-443份;香附328-336份;郁金327-335份;枸杞子435-443份;酸枣仁438-447份;龙骨438-447份;牡蛎438-447份;枳壳333-339份;佛手163-166份;木香162-165份;甜菊素16-18份。
作为本发明再进一步的方案:疏肝解郁中药包括以下重量份的原料:柴胡222份;白芍438份;北沙参438份;香附331份;郁金330份;枸杞子438份;酸枣仁441份;龙骨441份;牡蛎441份;枳壳336份;佛手165份;木香164份;甜菊素17份。
作为本发明再进一步的方案:所述香附为醋制香附,所述枳壳采用炒制而成。
疏肝解郁中药的制备方法,包括如下步骤:
步骤一,龙骨、牡蛎提取:按处方配比称取龙骨、牡蛎加水煎煮三次,每次1小时,滤过并浓缩;
步骤二,挥发油提取:按处方配比称取柴胡、香附、郁金和木香,加水提取挥发油3小时,收集挥发油,得药渣a和水煎液b;
步骤三,十味药材提取:将白芍、北沙参、枸杞子、酸枣仁、枳壳、佛手与药渣a加水浸泡1小时后,煎煮两次,每次1.5小时,滤过;
步骤四,浓缩:将水煎液b和步骤三中所得的十味药材提取液进行减压浓缩操作,在料液浓缩至适量时,向浓缩液加乙醇至含醇量达60%,混匀,静置24小时后,抽取上清液,回收乙醇浓缩至无醇味并抽入步骤一中所得的龙骨、牡蛎浓缩液浓缩至适量流浸膏;
步骤五,包合:将倍他环糊精加纯化水,在沸水浴中溶解,待温度降至45℃时加步骤二中所收集的挥发油并密闭搅拌2小时,冷藏24小时后滤过,用水洗涤容器,用石油醚洗涤滤渣,60℃减压干燥6小时;
步骤六,喷雾干燥:将适量糊精加入步骤五浓缩所得的流浸膏中喷雾干燥制成粉末;
步骤七,制粒:向步骤六中制成的粉末中加入适量糊精、甜菊素及β-CD包合物,混匀,制粒,低温干燥,即得该药物。
与现有技术相比,本发明的有益效果是:该中药具有疏肝解郁,理气和中的功能。拟治妇科经前期综合征,适用于肝郁气滞所致的经前乳房胀痛,胸闷肋涨,头晕头痛,烦躁易怒,失眠多梦等;通过对处方药物化学成分理化性质及药理作用的检索,结合本品的临床功效,确定柴胡、香附、郁金、木香四味先提取挥发油,并将挥发油用β-CD包合。药渣再与白芍等六味合并水煎提取,水煎液浓缩后用乙醇沉淀除杂。龙骨、牡蛎为了避免和群药共煎醇沉时有效成分损失,因此将二味单独煎煮浓缩后加入上述醇沉后的浓缩液中。
具体实施方式
下面将结合本发明实施例对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
实施例1
本发明实施例中,一种疏肝解郁中药,包括以下重量份的原料:柴胡210份;白芍420份;北沙参420份;香附314份;郁金312份;枸杞子420份;酸枣仁422份;龙骨422份;牡蛎422份;枳壳321份;佛手151份;木香150份;甜菊素13份。
所述香附为醋制香附,所述枳壳采用炒制而成;
该中药具有疏肝解郁,理气和中的功能。拟治妇科经前期综合征,适用于肝郁气滞所致的经前乳房胀痛,胸闷肋涨,头晕头痛,烦躁易怒,失眠多梦等。
“峏山杨氏妇科”为安徽著名中医妇科世家,自明朝初叶传承至今已历20余代,有600余年的历史,与庐江徐氏妇科、新安黄氏妇科并称为安徽三大中医妇科流派。“峏山杨氏妇科”有经验方用于妇女经前乳房胀痛、烦躁易怒、头晕头痛等症疗效显著,拟作为中药第6类新药上市。国家食品药品监管管理总局药物临床研究批件号:2004L04338。目前该品种已经进行部分临床探索,初步证明其治疗PMS的安全性和有效性、临床前研究表明该药物治疗PMS具有理论基础,且具有良好的安全性。
实施例2
一种疏肝解郁中药,包括以下重量份的原料:柴胡214份;白芍426份;北沙参426份;香附320份;郁金318份;枸杞子426份;酸枣仁430份;龙骨430份;牡蛎430份;枳壳326份;佛手154份;木香153份;甜菊素14份。
所述香附为醋制香附,所述枳壳采用炒制而成。
实施例3
一种疏肝解郁中药,包括以下重量份的原料:柴胡218份;白芍432份;北沙参432份;香附325份;郁金324份;枸杞子432份;酸枣仁435份;龙骨435份;牡蛎435份;枳壳330份;佛手160份;木香159份;甜菊素15份。
所述香附为醋制香附,所述枳壳采用炒制而成。
实施例4
一种疏肝解郁中药,包括以下重量份的原料:柴胡220份;白芍435份;北沙参435份;香附328份;郁金327份;枸杞子435份;酸枣仁438份;龙骨438份;牡蛎438份;枳壳333份;佛手163份;木香162份;甜菊素16份。
所述香附为醋制香附,所述枳壳采用炒制而成。
实施例5
一种疏肝解郁中药,包括以下重量份的原料:柴胡222份;白芍438份;北沙参438份;香附331份;郁金330份;枸杞子438份;酸枣仁441份;龙骨441份;牡蛎441份;枳壳336份;佛手165份;木香164份;甜菊素17份。
所述香附为醋制香附,所述枳壳采用炒制而成。
实施例6
一种疏肝解郁中药,包括以下重量份的原料:柴胡224份;白芍443份;北沙参443份;香附336份;郁金335份;枸杞子443份;酸枣仁447份;龙骨447份;牡蛎447份;枳壳339份;佛手166份;木香165份;甜菊素18份。
所述香附为醋制香附,所述枳壳采用炒制而成。
实施例7
一种疏肝解郁中药,包括以下重量份的原料:柴胡225份;白芍445份;北沙参445份;香附339份;郁金338份;枸杞子445份;酸枣仁450份;龙骨450份;牡蛎450份;枳壳342份;佛手168份;木香167份;甜菊素19份。
所述香附为醋制香附,所述枳壳采用炒制而成。
实施例8
一种疏肝解郁中药,包括以下重量份的原料:柴胡227份;白芍449份;北沙参449份;香附342份;郁金341份;枸杞子449份;酸枣仁455份;龙骨455份;牡蛎455份;枳壳344份;佛手171份;木香170份;甜菊素20份。
所述香附为醋制香附,所述枳壳采用炒制而成。
实施例9
本发明实施例中,一种疏肝解郁中药,包括以下重量份的原料:柴胡230份;白芍455份;北沙参455份;香附345份;郁金344份;枸杞子455份;酸枣仁460份;龙骨460份;牡蛎460份;枳壳350份;佛手175份;木香173份;甜菊素21份。
所述香附为醋制香附,所述枳壳采用炒制而成。
柴胡为方中君药,主要含有挥发油类:2-甲基环戊酮、柠檬烯、月桂烯、(+)-香芹酮等;亲水性的皂苷类:柴胡皂苷a、b、c、d及柴胡苷元E、F、份,龙吉苷元等有效成分。药理研究表明:柴胡具有解热作用,柴胡煎剂或柴胡皂苷对动物实验性发热均有解热作用;柴胡或柴胡皂苷具有镇痛、镇静、抗炎、抗病原体等作用。
香附、郁金、木香含有大量挥发性成分,具有保肝、镇痛、消炎等作用。
白芍为方中主要药味之一,含单萜类化合物芍药苷、芍药花苷、芍药内酯苷、氧化芍药苷等成分,此类成分在水中有较好的溶解度。药理研究表明:白芍具有抗炎、抗菌、抗病毒作用,以及镇痛、解痉、保肝等作用。
枸杞子含有胡萝卜素、硫胺素、甜菜碱、核黄素等成分,枸杞子水提取液或甜菜碱具有降血脂、保肝、抗脂肪肝等作用。
酸枣仁含三萜类成分白桦脂酸、白桦脂醇、酸枣仁皂苷A、B、B1及黄酮类等成分,均为亲水性成分。药理研究表明:酸枣仁具有镇静、抗惊、镇痛等作用;对于半数致惊厥量的戊四唑,酸枣仁水溶性提取物可明显降低惊厥率和死亡率。
北沙参含有珊瑚草素、佛手内酯、生物碱及微量挥发油,北沙参水提取液具有抗突变作用、镇痛作用。
枳壳、佛手主要含有橙皮苷等黄酮类化合物、及少量挥发油,枳壳经炒炙后挥发油含量减少。橙皮苷具有维持血管正常渗透压,降低血管脆性,缩短出血时间等作用。
龙骨、牡蛎主要含有碳酸钙、磷酸钙及多种微量元素,具有平肝潜阳,镇静安神收敛固涩之功。
实施例10
一种疏肝解郁中药的制备方法,包括如下步骤:
步骤一,龙骨、牡蛎提取:按处方配比称取龙骨、牡蛎加水煎煮三次,每次1小时,滤过并浓缩;
步骤二,挥发油提取:按处方配比称取柴胡、香附、郁金和木香,加水提取挥发油3小时,收集挥发油,得药渣a和水煎液b;
步骤三,十味药材提取:将白芍、北沙参、枸杞子、酸枣仁、枳壳、佛手与药渣a加水浸泡1小时后,煎煮两次,每次1.5小时,滤过;
步骤四,浓缩:将水煎液b和步骤三中所得的十味药材提取液进行减压浓缩操作,在料液浓缩至适量时,向浓缩液加乙醇至含醇量达60%,混匀,静置24小时后,抽取上清液,回收乙醇浓缩至无醇味并抽入步骤一中所得的龙骨、牡蛎浓缩液浓缩至适量流浸膏;
步骤五,包合:将倍他环糊精加纯化水,在沸水浴中溶解,待温度降至45℃时加步骤二中所收集的挥发油并密闭搅拌2小时,冷藏24小时后滤过,用水洗涤容器,用石油醚洗涤滤渣,60℃减压干燥6小时;
步骤六,喷雾干燥:将适量糊精加入步骤五浓缩所得的流浸膏中喷雾干燥制成粉末;
步骤七,制粒:向步骤六中制成的粉末中加入适量糊精、甜菊素及β-CD包合物,混匀,制粒,低温干燥,即得该药物。
制备工艺是根据处方中各味药所含化学成分的理化性质、药理作用、药效、临床、生产等多方面因素,经反复实验研究,分析比较而确定。
通过对处方药物化学成分理化性质及药理作用的检索,结合本品的临床功效,确定柴胡、香附、郁金、木香四味先提取挥发油,并将挥发油用β-CD包合。药渣再与白芍等六味合并水煎提取,水煎液浓缩后用乙醇沉淀除杂。龙骨、牡蛎为了避免和群药共煎醇沉时有效成分损失,因此将二味单独煎煮浓缩后加入上述醇沉后的浓缩液中。
对于本领域技术人员而言,显然本发明不限于上述示范性实施例的细节,而且在不背离本发明的精神或基本特征的情况下,能够以其他的具体形式实现本发明。因此,无论从哪一点来看,均应将实施例看作是示范性的,而且是非限制性的,本发明的范围由所附权利要求而不是上述说明限定,因此旨在将落在权利要求的等同要件的含义和范围内的所有变化囊括在本发明内。
此外,应当理解,虽然本说明书按照实施方式加以描述,但并非每个实施方式仅包含一个独立的技术方案,说明书的这种叙述方式仅仅是为清楚起见,本领域技术人员应当将说明书作为一个整体,各实施例中的技术方案也可以经适当组合,形成本领域技术人员可以理解的其他实施方式。
Claims (7)
1.一种疏肝解郁中药,其特征在于,所述疏肝解郁中药包括以下重量份的原料:柴胡210-230份;白芍420-455份;北沙参420-455份;香附314-345份;郁金312-344份;枸杞子420-455份;酸枣仁422-460份;龙骨422-460份;牡蛎422-460份;枳壳321-350份;佛手151-175份;木香150-173份;甜菊素13-21份。
2.根据权利要求1所述的一种疏肝解郁中药,其特征在于,包括以下重量份的原料:柴胡214-227份;白芍426-449份;北沙参426-449份;香附320-342份;郁金318-341份;枸杞子426-449份;酸枣仁430-455份;龙骨430-455份;牡蛎430-455份;枳壳326-344份;佛手154-171份;木香153-170份;甜菊素14-20份。
3.根据权利要求1所述的一种疏肝解郁中药,其特征在于,包括以下重量份的原料:柴胡218-225份;白芍432-445份;北沙参432-445份;香附325-339份;郁金324-338份;枸杞子432-445份;酸枣仁435-450份;龙骨435-450份;牡蛎435-450份;枳壳330-342份;佛手160-168份;木香159-167份;甜菊素15-19份。
4.根据权利要求1所述的一种疏肝解郁中药,其特征在于,包括以下重量份的原料:柴胡220-224份;白芍435-443份;北沙参435-443份;香附328-336份;郁金327-335份;枸杞子435-443份;酸枣仁438-447份;龙骨438-447份;牡蛎438-447份;枳壳333-339份;佛手163-166份;木香162-165份;甜菊素16-18份。
5.根据权利要求1所述的一种疏肝解郁中药,其特征在于,包括以下重量份的原料:柴胡222份;白芍438份;北沙参438份;香附331份;郁金330份;枸杞子438份;酸枣仁441份;龙骨441份;牡蛎441份;枳壳336份;佛手165份;木香164份;甜菊素17份。
6.根据权利要求1-5任一项所述的一种疏肝解郁中药,其特征在于,所述香附为醋制香附,所述枳壳采用炒制而成。
7.一种如权利要求1-5任一项所述的疏肝解郁中药的制备方法,其特征在于,包括如下步骤:
步骤一,龙骨、牡蛎提取:按处方配比称取龙骨、牡蛎加水煎煮三次,每次1小时,滤过并浓缩;
步骤二,挥发油提取:按处方配比称取柴胡、香附、郁金和木香,加水提取挥发油3小时,收集挥发油,得药渣a和水煎液b;
步骤三,十味药材提取:将白芍、北沙参、枸杞子、酸枣仁、枳壳、佛手与药渣a加水浸泡1小时后,煎煮两次,每次1.5小时,滤过;
步骤四,浓缩:将水煎液b和步骤三中所得的十味药材提取液进行减压浓缩操作,在料液浓缩至适量时,向浓缩液加乙醇至含醇量达60%,混匀,静置24小时后,抽取上清液,回收乙醇浓缩至无醇味并抽入步骤一中所得的龙骨、牡蛎浓缩液浓缩至适量流浸膏;
步骤五,包合:将倍他环糊精加纯化水,在沸水浴中溶解,待温度降至45℃时加步骤二中所收集的挥发油并密闭搅拌2小时,冷藏24小时后滤过,用水洗涤容器,用石油醚洗涤滤渣,60℃减压干燥6小时;
步骤六,喷雾干燥:将适量糊精加入步骤五浓缩所得的流浸膏中喷雾干燥制成粉末;
步骤七,制粒:向步骤六中制成的粉末中加入适量糊精、甜菊素及β-CD包合物,混匀,制粒,低温干燥,即得该药物。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111414634.8A CN113925946A (zh) | 2021-11-25 | 2021-11-25 | 一种疏肝解郁中药及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111414634.8A CN113925946A (zh) | 2021-11-25 | 2021-11-25 | 一种疏肝解郁中药及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113925946A true CN113925946A (zh) | 2022-01-14 |
Family
ID=79288403
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111414634.8A Pending CN113925946A (zh) | 2021-11-25 | 2021-11-25 | 一种疏肝解郁中药及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113925946A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116870121A (zh) * | 2023-08-18 | 2023-10-13 | 北京中医药大学东方医院 | 一种治疗双心病的中药组合物及其制备方法和应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101152532A (zh) * | 2007-09-30 | 2008-04-02 | 杨波 | 一种治疗妇科疾病的中药制剂 |
-
2021
- 2021-11-25 CN CN202111414634.8A patent/CN113925946A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101152532A (zh) * | 2007-09-30 | 2008-04-02 | 杨波 | 一种治疗妇科疾病的中药制剂 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116870121A (zh) * | 2023-08-18 | 2023-10-13 | 北京中医药大学东方医院 | 一种治疗双心病的中药组合物及其制备方法和应用 |
CN116870121B (zh) * | 2023-08-18 | 2024-04-02 | 北京中医药大学东方医院 | 一种治疗双心病的中药组合物及其制备方法和应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103039970B (zh) | 一种具有耐缺氧、抗疲劳的营养保健品的活性成分及其制备方法 | |
CN101152288B (zh) | 一种具有解酒作用的中药 | |
CN104258193A (zh) | 一种治疗神经衰弱和预防老年痴呆症的药物组合物 | |
CN105148288A (zh) | 一种环糊精以及改性环糊精辅助提取中药有效成分的方法 | |
CN104958219A (zh) | 一种金钗石斛牙膏及其制作方法 | |
CN113925946A (zh) | 一种疏肝解郁中药及其制备方法 | |
CN101011562A (zh) | 参芪温胆汤新剂型及其生产方法 | |
CN113730514A (zh) | 助于提高免疫力的配制酒组合物及其制备方法和使用方法 | |
CN111419946A (zh) | 一种治疗不育症的药物及其制备方法 | |
CN101721543A (zh) | 一种治疗妇科疾病的纯中药洗液 | |
CN109731074A (zh) | 一种缓解眼疲劳和干眼症的内服和外用套装及其制备方法 | |
CN104906366A (zh) | 一种治疗月经后期的药物制剂 | |
CN101590130A (zh) | 治疗便秘的贴剂 | |
CN101310739B (zh) | 一种桂枝茯苓组合物及其制备方法 | |
CN114404517A (zh) | 一种用于痛风和降低尿酸的组合物及其用途与制备方法 | |
CN103735871A (zh) | 一种治疗神经衰弱的中药组合物及其制备方法 | |
CN103536819B (zh) | 灵芝培元组合物、酒剂及其制作方法和用途 | |
CN102824550A (zh) | 复方天麻制剂的制作方法 | |
CN102120000B (zh) | 抗柯萨奇b病毒中药制剂有效部位的组合物及其制备方法 | |
CN105125898A (zh) | 一种含黄芪和天麻具有益气补血的药物制剂 | |
CN118557656B (zh) | 一种中药组合物在制备治疗神经系统疾病药物中的应用 | |
CN105168519B (zh) | 具有改善睡眠功能的组合物及其制备方法和应用 | |
CN101167762B (zh) | 一种具有抗突变、免疫调节作用的保健胶囊的制备方法 | |
CN114869935A (zh) | 一种天然植物育发生发液及其制备方法 | |
CN101518623A (zh) | 一种治疗慢性肾炎的中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220114 |